Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04637 (
p53
)
77,613
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
p53 tumor suppressor
gene encodes a transcription factor, which is translationally and posttranslationally activated after DNA damage. In a proteomic screen for
p53
interactors, we found that the cullin protein Cul7 efficiently associates with
p53
. After DNA damage, the level of Cul7 protein increased in a caffeine-sensitive, but
p53
-independent, manner. Down-regulation of Cul7 by conditional microRNA expression augmented
p53
-mediated inhibition of cell cycle progression. Ectopic expression of Cul7 inhibited activation of
p53
by DNA damaging agents and sensitized cells to adriamycin. Although Cul7 recruited the F-box protein FBX29 to
p53
, the combined expression of Cul7/
FBX29
did not promote ubiquitination and degradation of
p53
in vivo. Therefore, the inhibition of
p53
activity by Cul7 is presumably mediated by alternative mechanisms. The interplay between
p53
and Cul7 resembles the negative feedback loop described for
p53
and Mdm2. Pharmacological modulation of Cul7 function may allow the sensitization of cancer cells expressing wild-type
p53
to genotoxic agents used in cancer therapy.
...
PMID:Induction of cullin 7 by DNA damage attenuates p53 function. 1758 86